Dermatologicals in Denmark
DERMATOLOGICALS IN DENMARK
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Consumer Desire for Privacy Supports Growth in Online Sales
Hair Loss Treatments Is Among Few Declining Categories
Competitive Landscape
Dermatologicals in Denmark Continues To Be Dominated by Multinationals
Private Label Struggles Against Strong Brands
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Continued Growth for Consumer Health in Denmark in 2018
Value Growth Is Slightly Faster in 2018 Than Over the Review Period
Private Label Remains Marginal But Gains Ground
Chemists/pharmacies Remains the Leading Distribution Channel
Moderate Growth Rates Expected Over the Forecast Period
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Sources
Summary 2 Research Sources
Social stigma associated with skin conditions slowly started waning in Denmark but continued to support growth of internet sales for dermatologicals in 2018. Although marketing campaigns and a generally more open attitude towards health-related issues in Denmark helped minimise the embarrassment some consumers felt about discussing these issues there remained a certain level of social stigma related to products such as haemorrhoid treatments, vaginal antifungals and antiparasitics/lice treatment...
Euromonitor International's Dermatologicals in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.